Vimarsana
Biggest News Aggregation in the World

Page 12 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

Small Pharma (CVE:DMT) Trading Down 6.3% - Vimarsana News

Small Pharma (CVE:DMT) Trading Down 6.3%

Small Pharma Inc. (CVE:DMT – Get Free Report)’s share price fell 6.3% on Tuesday . The company traded as low as C$0.15 and last traded at C$0.15. 1,890,765 shares traded hands during trading, an increase of 538% from the average session volume of 296,159 shares. The stock had previously closed at C$0.16. Small Pharma Trading […]

HOOKIPA Pharma to Host Investor Call on HB-200 and Planned - Vimarsana News

HOOKIPA Pharma to Host Investor Call on HB-200 and Planned

HOOKIPA announces alignment with FDA on pivotal trial design and protocol for HB-200 in combination with pembrolizumabHB-200 program receives Priority...

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum - Vimarsana News

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

MEI Pharma, Inc. , a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced that David...

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio - Vimarsana News

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio

/PRNewswire/ -- The global central nervous system (cns) stimulant drugs market size is estimated to grow by USD 6486.71 mn from 2023-2027, according to...

IGC Pharma Adds Advisor in Artificial Intelligence - Vimarsana News

IGC Pharma Adds Advisor in Artificial Intelligence

IGC Pharma, Inc. today announces the addition of Pablo Arbelaez, Ph.D., an expert in artificial intelligence and one of the world's top researchers. Dr. Arbelaez will support the development of...